| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-05 10:21:51 UTC |
|---|
| Updated at | 2022-09-05 10:21:51 UTC |
|---|
| NP-MRD ID | NP0211895 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid |
|---|
| Description | Chymostatin belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. (2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid is found in Streptomyces lavendulae. (2s)-2-{n-[(s)-(2-imino-1,3-diazinan-4-yl)({[(1s)-3-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl})methyl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid was first documented in 2021 (PMID: 34079459). Based on a literature review a small amount of articles have been published on Chymostatin (PMID: 35921955) (PMID: 35910377) (PMID: 35215131) (PMID: 33687310). |
|---|
| Structure | CC(C)C[C@H](N=C(O)[C@@H](NC(O)=N[C@@H](CC1=CC=CC=C1)C(O)=O)C1CCNC(=N)N1)C(O)=N[C@@H](CC1=CC=CC=C1)C=O InChI=1S/C31H41N7O6/c1-19(2)15-24(27(40)34-22(18-39)16-20-9-5-3-6-10-20)35-28(41)26(23-13-14-33-30(32)36-23)38-31(44)37-25(29(42)43)17-21-11-7-4-8-12-21/h3-12,18-19,22-26H,13-17H2,1-2H3,(H,34,40)(H,35,41)(H,42,43)(H3,32,33,36)(H2,37,38,44)/t22-,23?,24-,25-,26-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C31H41N7O6 |
|---|
| Average Mass | 607.7120 Da |
|---|
| Monoisotopic Mass | 607.31183 Da |
|---|
| IUPAC Name | (2S)-2-{N-[(S)-(2-imino-1,3-diazinan-4-yl)({[(1S)-3-methyl-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]-C-hydroxycarbonimidoyl}butyl]-C-hydroxycarbonimidoyl})methyl]-(C-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid |
|---|
| Traditional Name | (2S)-2-{N-[(S)-(2-imino-1,3-diazinan-4-yl)({[(1S)-3-methyl-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]-C-hydroxycarbonimidoyl}butyl]-C-hydroxycarbonimidoyl})methyl]-(C-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)C[C@H](N=C(O)[C@@H](NC(O)=N[C@@H](CC1=CC=CC=C1)C(O)=O)C1CCNC(=N)N1)C(O)=N[C@@H](CC1=CC=CC=C1)C=O |
|---|
| InChI Identifier | InChI=1S/C31H41N7O6/c1-19(2)15-24(27(40)34-22(18-39)16-20-9-5-3-6-10-20)35-28(41)26(23-13-14-33-30(32)36-23)38-31(44)37-25(29(42)43)17-21-11-7-4-8-12-21/h3-12,18-19,22-26H,13-17H2,1-2H3,(H,34,40)(H,35,41)(H,42,43)(H3,32,33,36)(H2,37,38,44)/t22-,23?,24-,25-,26-/m0/s1 |
|---|
| InChI Key | MRXDGVXSWIXTQL-HYHFHBMOSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Phenylalanine or derivatives
- Leucine or derivatives
- N-acyl-alpha amino acid or derivatives
- N-carbamoyl-alpha-amino acid
- N-carbamoyl-alpha-amino acid or derivatives
- Alpha-amino acid amide
- 3-phenylpropanoic-acid
- Beta amino acid or derivatives
- N-substituted-alpha-amino acid
- Amphetamine or derivatives
- Alpha-amino acid or derivatives
- Fatty acyl
- Fatty amide
- Benzenoid
- Hydropyrimidine
- 1,4,5,6-tetrahydropyrimidine
- N-acyl-amine
- Monocyclic benzene moiety
- Carboxamide group
- Guanidine
- Urea
- Secondary carboxylic acid amide
- Carbonic acid derivative
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Carbonyl group
- Aldehyde
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Organooxygen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Liu S, Suzuki Y, Takemasa E, Watanabe R, Mogi M: Mast cells promote viral entry of SARS-CoV-2 via formation of chymase/spike protein complex. Eur J Pharmacol. 2022 Sep 5;930:175169. doi: 10.1016/j.ejphar.2022.175169. Epub 2022 Jul 31. [PubMed:35921955 ]
- Porta EOJ, Isern JA, Kalesh K, Steel PG: Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling. Front Pharmacol. 2022 Jul 15;13:929493. doi: 10.3389/fphar.2022.929493. eCollection 2022. [PubMed:35910377 ]
- Vellasco L, Svensjo E, Bulant CA, Blanco PJ, Nogueira F, Domont G, de Almeida NP, Nascimento CR, Silva-Dos-Santos D, Carvalho-Pinto CE, Medei EH, Almeida IC, Scharfstein J: Sheltered in Stromal Tissue Cells, Trypanosoma cruzi Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway. Pathogens. 2022 Jan 29;11(2):187. doi: 10.3390/pathogens11020187. [PubMed:35215131 ]
- Baranowska I, Gawrys O, Roszkowska-Chojecka MM, Badzynska B, Tymecka D, Olszynski KH, Kompanowska-Jezierska E: Chymase Dependent Pathway of Angiotensin II Generation and Rapeseed Derived Peptides for Antihypertensive Treatment of Spontaneously Hypertensive Rats. Front Pharmacol. 2021 May 17;12:658805. doi: 10.3389/fphar.2021.658805. eCollection 2021. [PubMed:34079459 ]
- Roszkowska-Chojecka MM, Baranowska I, Gawrys O, Sadowski J, Walkowska A, Kalisz M, Litwiniuk A, Kompanowska-Jezierska E: Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in spontaneously hypertensive rats. Clin Exp Hypertens. 2021 Jul 4;43(5):392-401. doi: 10.1080/10641963.2021.1890762. Epub 2021 Mar 9. [PubMed:33687310 ]
- LOTUS database [Link]
|
|---|